[go: up one dir, main page]

WO2012019789A1 - Preparations comprising benzethonium chloride and silver citrate - Google Patents

Preparations comprising benzethonium chloride and silver citrate Download PDF

Info

Publication number
WO2012019789A1
WO2012019789A1 PCT/EP2011/054430 EP2011054430W WO2012019789A1 WO 2012019789 A1 WO2012019789 A1 WO 2012019789A1 EP 2011054430 W EP2011054430 W EP 2011054430W WO 2012019789 A1 WO2012019789 A1 WO 2012019789A1
Authority
WO
WIPO (PCT)
Prior art keywords
benzethonium chloride
emulsion
preparations
silver citrate
preservation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/054430
Other languages
German (de)
French (fr)
Inventor
Bernd Traupe
Manuela Köhler
Gitta Neufang
Antonia Wagner
Andreas Firyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Priority to DE112011102427T priority Critical patent/DE112011102427A5/en
Publication of WO2012019789A1 publication Critical patent/WO2012019789A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/002Aftershave preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds

Definitions

  • the invention relates to a preparation containing a combination of quaternary ammonium salt and silver citrate. All quantities are - unless otherwise stated - percentages by weight based on the total mass of the preparation.
  • Silver SDC for the purposes of the present specification is Tinosan SDC from CIBA and consists chemically of Citric Acid + Silver Citrate.
  • Benzethonium chloride is. It is thereby achieved that it is possible to use a quaternary ammonium salt which is already effective at low levels per se even at lower levels. This not only reduces the possibility of discomfort but also offers benefits in terms of formula stability. It is particularly preferred if the preparation is in the form of a w / o emulsion, o / w emulsion, w / o / w emulsion, high internal phase emulsion, w / si emulsion, si / w emulsion, a hydrogel, a gel cream, a Gels or as a solid formulation such as a bar of soap or lipstick is present. Due to the reduced use concentration of the quaternary ammonium salt is achieved that any formula instabilities that are observed by adding cationic substances from time to time are observed even less frequently. Further, it is preferable if
  • Benzethonium chloride is present in a concentration of 0.001 to 0.1%. This ensures that the likelihood of a malady is significantly reduced. It is very particularly preferred if silver citrate is present in a concentration of 1 to 20 ppm. This ensures that the synergistic effect and thus the possibility of
  • Benzethonium chloride and silver citrate for improving the preservation of cosmetic preparations, more preferably in a concentration of 0.001 to 0.1%.
  • the invention also encompasses the use of preparations according to the invention for the production of deodorant preparations and after-save products.
  • Such preparations may additionally comprise 2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); Titanium dioxide, zinc oxide, 2,4,6-tris- (biphenyl) -1, 3,5-triazine, (2- ⁇ 4- [2- (4-diethylamino-2-hydroxybenzoyl) benzoyl] -piperazine- 1-carbonyl ⁇ -phenyl) - (4-diethylamino-2-hydroxy-phenyl) -methanone.
  • B. jojoba oil Dialkyl ethers and dialkyl carbonates in particular. Dicaprylyl ether and / or di-caprylylcarbona, soicosane, neopentyl glycol diheptanoate, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, Ci 2 -13-alkyl lactate, di-Ci 2 -13-alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate,
  • Polyglyceryl-3 polydimethylsiloxyethyl dimethicone, acrylates / C 10-30 alkyl acrylates
  • the bacterium S. aureus was from a according to EN 12353
  • the reduction factor is the factor by which the cell number (CFU) of the test substance is reduced compared to the control.
  • This effect can even be repeated at 8 ppm (see table), so it can not be a randomly observed effect.
  • Carbomer (Carbopol 981) 0.2 0.3 0.2 0.4 0.15
  • Carrageenan (Chondrus Crispus) (Gelcarin) - - - - - 2
  • Hamamelis extract Hamamelis (extract PG) 0, 1 0.2 0.3 0.4 -
  • Xanthan Gum (Xanthan gum E 415 food 0.2 0.2 grade)
  • Panthenol 1 50 - - 0.70 - 0.00
  • Polyglyceryl-10 Stearate 0.70 - 1, 80 1, 00 - 1, 00
  • Titanium dioxide + trimethoxycaprylylsilane (Tego Sun T 805) 0.3600
  • Triglycerol diisostearate 1 0 0.5 0.25 2.0 3.0
  • Paraffin oil (Shell Ondina 917) 12.5 10.0 8.0 5.0 1 1, 5
  • Vaseline (Pioneer 6787) 8.0 6.0 5.0 12.0 2.5
  • Dicaprylyl carbonate 0, 1 0.05 0, 15 0.5 1, 0 hydrogenated castor oil 0.5 0.75 1, 0 2.5 5.0

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a cosmetic preparation containing a combination of a quaternary ammonium salt and silver citrate and is characterised inter alia in that a synergy is observed in respect of preservation and hence the application concentration needed for preservation is reduced.

Description

ZUBEREITUNGEN MIT BENZETHONIUMCHLORID UND SILBERCITRAT  PREPARATIONS WITH BENZETHONIUM CHLORIDE AND SILVER CITRATE

Die Erfindung betrifft eine Zubereitung enthaltend eine Kombination aus quaternärem Ammoniumsalz und Silbercitrat Alle Mengenangaben sind - sofern nicht anders angegeben - Massenprozente bezogen auf die Gesamtmasse der Zubereitung. The invention relates to a preparation containing a combination of quaternary ammonium salt and silver citrate. All quantities are - unless otherwise stated - percentages by weight based on the total mass of the preparation.

Silver SDC im Sinne der vorliegenden Schrift ist Tinosan SDC von CIBA und besteht chemisch aus Citric Acid + Silver Citrate. Silver SDC for the purposes of the present specification is Tinosan SDC from CIBA and consists chemically of Citric Acid + Silver Citrate.

Damit Cremes und Lotionen nach dem Öffnen noch einige Monate haltbar sind, müssen sie konserviert werden. Jede Konservierung bedeutet den Wunsch auf der einen Seite ein gutes sicheres Produkt, das nach einigen Monaten noch gut riecht, ansehnlich ist und nicht durch Verkeimung eine Gefahr für den Verbraucher darstellt, dass auf der anderen Seite aber auch ausgezeichnet verträglich ist. Entscheidend ist die Wahl der Mittel. Einige Konservierungsmittel sind sehr wirksam, rufen jedoch bei einzelnen Verbrauchern Missempfinden hervor. So stehen zum Beispiel Parabene im Verdacht bei einem gewissen Teil der Menschheit ein Prickeln, Jucken oder Brennen hervorzurufen. Dieses Problem kann man umgehen, indem man diese Konservierungsmittel (Route I) vermeidet. In diesem Fall ist man sehr stark beschränkt in der Auswahl der Konservierung. Eine andere Möglichkeit ist es, Kombinationen zu verwenden, die sehr gut wirken, und gleichzeitig von den einzelnen Komponenten weniger enthalten (Route II). Stand der Technik findet sich in JP 2007284412, JP 20081 10999, EP 1964543, To keep creams and lotions stable for a few months after opening, they must be preserved. Every preservation means a desire on the one hand a good safe product that smells good after a few months, is handsome and does not pose a danger to the consumer through microbial contamination, but on the other hand is also very well tolerated. The decisive factor is the choice of means. Some preservatives are very effective, but cause discomfort to individual consumers. For example, parabens are suspected of causing a certain amount of humanity to tingle, itch, or burn. This problem can be avoided by avoiding these preservatives (Route I). In this case, one is very limited in the choice of preservation. Another option is to use combinations that work very well, but at the same time contain less of the individual components (Route II). Prior art can be found in JP 2007284412, JP 20081 10999, EP 1964543,

WO2005102046, WO 2001041573. WO2005102046, WO 2001041573.

All dies konnte die Mängel des Standes der Technik nicht beseitigen. Dem Stand der Technik fehlte es an Zubereitungen, die eine gute Konservierung ermöglichen und gleichzeitig auf den Einsatz von Parabenen zu verzichten und so bei vielen Anwendern ein Prickeln, Jucken oder Brennen zu vermeiden. Überraschend und für den Fachmann nicht vorhersehbar hat sich nun herausgestellt, dass eine kosmetische Zubereitung enthaltend eine Kombination aus quaternärem Ammoniumsalz und Silbercitrat, dadurch gekennzeichnet das bezüglich der Konservierung eine Synergie zu beobachten ist und mit die zur Konservierung notwendige Einsatzkonzentration herabgesenkt wird den Mängeln des Standes der Technik abhilft. Dadurch wird erreicht, dass man weniger von einem quaternären Ammoniumsalz einsetzen muss für die gleiche Konservierungsleistung. Dies ist von Vorteil, da quaternäre Ammoniumsalze im Verdacht sind bei Konsumenten Missempfinden auszulösen, insbesondere bei empfindlicher oder verletzter Haut. Durch die Synergie kann die Konzentration des quaternären Ammoniumsalzes deutlich reduziert werden und damit auch die Wahrscheinlichkeit des Missempfindens. Bevorzugt ist es, wenn, die quaternäre Ammoniumverbindung All this could not eliminate the shortcomings of the prior art. The state of the art lacked preparations that allow good preservation while avoiding the use of parabens and thus avoid tingling, itching or burning in many users. Surprisingly and unforeseeable for a person skilled in the art, it has now turned out that a cosmetic preparation containing a combination from quaternary ammonium salt and silver citrate, characterized in that with respect to the preservation of a synergy is observed and is lowered with the necessary concentration for preservation use the shortcomings of the prior art remedies. This ensures that less of a quaternary ammonium salt must be used for the same conservation performance. This is advantageous because quaternary ammonium salts are suspected to cause consumer discomfort, especially with sensitive or damaged skin. Due to the synergy, the concentration of the quaternary ammonium salt can be significantly reduced, and thus the likelihood of discomfort. It is preferred if, the quaternary ammonium compound

Benzethoniumchlorid ist. Dadurch wird erreicht, dass man ein per se bei geringen Mengen schon gut wirksames quaternäres Ammoniumsalz bei noch geringeren Mengen einsetzen kann. Das mindert nicht nur die Möglichkeit des Missempfindens sondern bietet auch Vorteile bezüglich der Formelstabilität. Besonders bevorzugt ist es, wenn die Zubereitung in Form einer w/o Emulsion, o/w Emulsion, w/o/w Emulsion, High Internal Phase Emulsion, w/si Emulsion, si/w Emulsion, eines Hydrogels, einer Gelecreme, eines Gels oder als feste Formulierung wie zum Beispiel eines Seifenstücks oder Lippenstiftes vorliegt. Durch die verringerte Einsatzkonzentration des quaternären Ammoniumsalzes wird erreicht, dass eventuelle Formelinstabilitäten, die man durch Zugabe kationischer Substanzen von Zeit zu Zeit beobachtet werden noch seltener Beobachtet werden. Weiter ist es bevorzugt, wenn Benzethonium chloride is. It is thereby achieved that it is possible to use a quaternary ammonium salt which is already effective at low levels per se even at lower levels. This not only reduces the possibility of discomfort but also offers benefits in terms of formula stability. It is particularly preferred if the preparation is in the form of a w / o emulsion, o / w emulsion, w / o / w emulsion, high internal phase emulsion, w / si emulsion, si / w emulsion, a hydrogel, a gel cream, a Gels or as a solid formulation such as a bar of soap or lipstick is present. Due to the reduced use concentration of the quaternary ammonium salt is achieved that any formula instabilities that are observed by adding cationic substances from time to time are observed even less frequently. Further, it is preferable if

Benzethoniumchlorid in einer Konzentration von 0,001 bis 0,1 % vorliegt. Dadurch wird erreicht, dass die Wahrscheinlichkeit eines Missempfindens deutlich reduziert wird. Ganz besonders bevorzugt ist es, wenn Silbercitrat in einer Konzentration von 1 bis 20 ppm vorliegt. Dadurch wird erreicht, dass der synergistische Effekt und damit die Möglichkeit der Benzethonium chloride is present in a concentration of 0.001 to 0.1%. This ensures that the likelihood of a malady is significantly reduced. It is very particularly preferred if silver citrate is present in a concentration of 1 to 20 ppm. This ensures that the synergistic effect and thus the possibility of

Reduktionder quaternären Ammoniumkomponente besonders deutlich wahrgenommen wer- den kann/besonders effizient ist. Die Erfindung umfasst auch die Verwendung von Reduction of the quaternary ammonium component can be perceived particularly clearly / is particularly efficient. The invention also includes the use of

Benzethoniumchlorid und Silbercitrat zur Verbesserung der Konservierung von kosmetischen Zubereitungen, besonders bevorzugt in einer Konzentration von 0,001 bis 0,1 %. Die Erfindung umfasst auch die Verwendung von erfindungsgemäßen Zubereitungen zur Herstellung von Deo-Zubereitungen und After Save Produkten.  Benzethonium chloride and silver citrate for improving the preservation of cosmetic preparations, more preferably in a concentration of 0.001 to 0.1%. The invention also encompasses the use of preparations according to the invention for the production of deodorant preparations and after-save products.

Vorteilhaft können solche Zubereitungen zusätzlich 2'-Methylen-bis-(6-(2H-benzotriazol-2-yl)- 4-(1 , 1 ,3,3-tetramethylbutyl)-phenol); Titandioxid, Zinkoxid, 2,4,6-Tris-(biphenyl)-1 ,3,5-triazin, (2-{4-[2-(4-Diethylamino-2-Hydroxy-Benzoyl)-Benzoyl]-Piperazine-1-Carbonyl}-Phenyl)-(4- Diethylamino-2-Hydroxy-Phenyl)-Methanon. Phenylen-1 ,4-bis-(2-benzimidazyl)-3,3'-5,5'- tetrasulfonsäuresalze; 2-Phenylbenzimidazol-5-sulfonsäuresalze; 1 ,4-di(2-oxo-10-Sulfo-3- bornylidenmethyl)-Benzol und dessen Salze; 4-(2-Oxo-3-bornylidenmethyl)ben- zolsulfonsäuresalze; 2-Methyl-5-(2-oxo-3-bornylidenmethyl)sulfonsäuresalze; 2; 2-(2H-ben- zotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1 ,3,3,3-tetramethyl-1 -[(trimethylsilyl)oxy nyl]propyl]-phenol; 3-(4-Methylbenzyliden)campher; 3-Benzylidencampher; Such preparations may additionally comprise 2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); Titanium dioxide, zinc oxide, 2,4,6-tris- (biphenyl) -1, 3,5-triazine, (2- {4- [2- (4-diethylamino-2-hydroxybenzoyl) benzoyl] -piperazine- 1-carbonyl} -phenyl) - (4-diethylamino-2-hydroxy-phenyl) -methanone. Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2; 2- (2H-benzyl zotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy nyl] propyl] phenol; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor;

Ethylhexylsalicylat, Terephthalidendicamphersulfonsäure; 4-(Dimethylamino)- benzoesäure(2-ethylhexyl)ester; 4-(Dimethylamino)benzoesäure-amylester; 4- Methoxybenzalmalon-säuredi(2-ethylhexyl)ester; 4-Methoxyzimtsäure(2-ethylhexyl)ester; 4- Methoxyzimtsäureisoamylester; 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy- 4'-methylbenzophenon; 2,2'-Dihydroxy-4-methoxybenzophenon; 2-(4'-Diethylamino-2'- hydoxybenzoyl)-benzoesäurehexylester, 4-(tert.-Butyl)-4'-methoxydibenzoylmethan; Ethylhexyl salicylate, terephthalidene dic- camphorsulfonic acid; 2-ethylhexyl 4- (dimethylamino) benzoate; 4- (dimethylamino) benzoic acid amyl ester; Di (2-ethylhexyl) -4-methoxybenzalmalonate; 4-methoxycinnamate (2-ethylhexyl) ester; 4-methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate, 4- (tert-butyl) -4'-methoxydibenzoylmethane;

Homomenthylsalicylat; 2-Ethylhexyl-2-hydroxybenzoat; 2-Ethylhexyl-2-cyano-3,3-diphenyl- acrylat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phe- noxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; 2,4-Bis-{[4-(2-ethyl-hexyl- oxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1 ,3,5-triazin (I NCI :Bis-Ethylhexyloxyphenol Methoxyphenyl Triazin); Dioctylbutylamidotriazon (I NCI : Diethylhexyl-Butamidotriazone); 2,4- bis-[5-1 (dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1 ,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1 ,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris- (2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1 '-hexyloxy)]-1 ,3,5-triazin (I NCI: Ethylhexyl Triazone); Merocyanine, Tapiocastärke, Distärkephosphat, Aluminium- bzw. Natrium-Stärke Octenylsuccinat und dergleichen, Cellulosen und Cellulosederivate, homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; 2,4-bis - {[4- (2-ethyl-hexyl-oxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (I NCI: bis-ethylhexyloxyphenol Methoxyphenyl triazine); Dioctylbutylamidotriazone (I NCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS Nos 288254-16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino - (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (I NCI: ethylhexyl triazone); merocyanines, tapioca starch, distarch phosphate, aluminum or sodium starch, octenyl succinate and the like, Celluloses and cellulose derivatives,

Polymethylsilesquioxane, emulgierende Silikonelastomere, nichtemulgierende Silikonelastomere, Polymethylmethacrylate, Polymethylmethacrylate Crosspolymer, Polyamide, Nylon, Polyethylen-Pulver, Talkum, beschichtetes Talkum, z.B. mit Dimethicone und Polymethylsilkenoxanes, emulsifying silicone elastomers, non-emulsifying silicone elastomers, polymethylmethacrylates, polymethylmethacrylate crosspolymer, polyamides, nylon, polyethylene powder, talc, coated talc, e.g. with Dimethicone and

Trimethylsiloxysilicate, Mica, Silica, Titandioxid (wahlweise hydrophil oder hydophob beschichtet, oder auch unbeschichtet) Silikonöle, Phenethylbenzoat, 2-Phenylethylbenzoat, Propylheptyl Caprylate, Isopropyl Lauroyl Sarkosinat, Dibutyladipat, Octylpalmitat, Octylco- coat, Octylisostearat, Octyldodeceylmyristat, Octyldodekanol, Cetearylisononanoat, Trimethylsiloxysilicate, mica, silica, titanium dioxide (optionally hydrophilic or hydrophobically coated, or else uncoated) silicone oils, phenethylbenzoate, 2-phenylethylbenzoate, propylheptyl caprylate, isopropyl lauroyl sarcosinate, dibutyl adipate, octyl palmitate, octylcoate, octyl isostearate, octyldodeceyl myristate, octyldodecanol, cetearyl isononanoate,

Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropyloleat, n-Butylstearat, n- Hexyllaurat, n-Decyloleat, Isooctylstearat, Isononylstearat, Isononylisononanoat, 2-Ethyl- hexylpalmitat, 2-Ethylhexyllaurat, 2-Hexyldecylstearat, 2-Octyldodecylpalmitat, Stearyl- heptanoat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat, Tridecylstearat, Tridecyltri- mellitat, sowie synthetische, halbsynthetische und natürliche Gemische solcher Ester, wie z. B. Jojobaöl. Dialkylether und Dialkylcarbonate insbesondere. Dicaprylylether und/oder Di- caprylylcarbona, soeikosan, Neopentylglykoldiheptanoat, Propylenglykoldicaprylat/dicaprat, Caprylic/Capric/Diglycerylsuccinat, Butylenglykol Dicaprylat/Dicaprat, Ci2-13-Alkyllactat, Di- Ci2-13-Alkyltartrat, Triisostearin, Dipentaerythrityl Hexacaprylat/Hexacaprat, Isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearylheptanoate, oleyl oleate, Oleylerucat, erucyl oleate, erucyl erucate, tridecyl stearate, Tridecyltri- mellitat, and synthetic, semi-synthetic and natural mixtures of such esters, such. B. jojoba oil. Dialkyl ethers and dialkyl carbonates in particular. Dicaprylyl ether and / or di-caprylylcarbona, soicosane, neopentyl glycol diheptanoate, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, Ci 2 -13-alkyl lactate, di-Ci 2 -13-alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate,

Propylenglykolmonoisostearat, Tricaprylin, Dimethylisosorbid, Caprylic/Capric Triglyceride, Octyldodecanol, C12-15 Alkyl Benzoate, Butylenglycol Dicaprylat/Dicaprat, Dicaprylyl Car- bonat, Isopropyl Palmitate, Ethylhexyl Cocoate, Cera Microcristallina + Paraffinum Liquidum, Butyrospermum Parkii, Dicaprylyl Ether, Hydrogenated Coco-Glycerides, Simmondsia Chinensis Oil, Tridecyl Stearate, Tridecyl Trimellitate, Dipentaerythrityl Propylene glycol monoisostearate, tricaprylin, dimethylisosorbide, caprylic / capric triglycerides, octyldodecanol, C12-15 alkyl benzoates, butylene glycol dicaprylate / dicaprate, dicaprylyl carbonate, isopropyl palmitate, ethylhexyl cocoate, cera microcristallina + paraffinum liquidum, Butyrospermum Parkii, Dicaprylyl Ether, Hydrogenated Coco-Glycerides, Simmondsia Chinensis Oil, Tridecyl Stearate, Tridecyl Trimellitate, Dipentaerythrityl

Hexacaprylate/Hexacaprate, Lanolin Alkohol. Glycerylstearatcitrat, Glycerylstearat (selbst- emulgierend), Stearinsäure, Stearatsalze, Polyglyceryl-3-methylglycosedistearat, Ceteareth- 20, PEG-40 Stearat , PEG-100 Stearat, Sucrose Polystearate in Kombination mit hydriertem Polyisobuten, Natriumstearoylglutamat, Cetearylalkohol in Kombination mit PEG-40 hydriertes Rizinusöl, Natriumcetearylsulfat, Glycerylstearat, Kaliumcetylphosphat , Polyglyceryl-3 Disiloxane Dimethicone Sorbitan Stearate, Silikonpolyether Copolymere wie zum Beispiel PEG-10 Dimethicone, PEG/PPG-14/4 Dimethicone, Glyceryl Stearate Citrate und/oder Sodium Stearoyl Glutamate, Ceteareth-n mit n= 5-50, Sorbitan Oleate, Distearyldimonium Chloride, Stearyl Dimethicone, Lecithin, Sodium Dihydroxycetyl Phosphate, PG-10 Stearate, Lauryl PEG/PPG-18/18 Methicone, Cetyl PEG/PPG-10/1 Dimethicone, Polyglyceryl-2 Caprate, Isostearyl Diglyceryl Succinate, Cetyl Phosphate, Sorbitan Sesquioleate, Hexacaprylate / hexacaprate, lanolin alcohol. Glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate, ceteareth-20, PEG-40 stearate, PEG-100 stearate, sucrose polystearates in combination with hydrogenated polyisobutene, sodium stearoyl glutamate, cetearyl alcohol in combination with PEG-40 hydrogenated castor oil, sodium cetearyl sulfate, glyceryl stearate, potassium cetyl phosphate, polyglyceryl-3 disiloxanes dimethicone sorbitan stearates, silicone polyether copolymers such as PEG-10 dimethicones, PEG / PPG-14/4 dimethicones, glyceryl stearate citrates and / or sodium stearoyl glutamates, ceteareth-n with n = 5-50, sorbitan oleate, distearyldimonium chloride, stearyl dimethicone, lecithin, sodium dihydroxycetyl phosphate, PG-10 stearate, lauryl PEG / PPG-18/18 methicone, cetyl PEG / PPG-10/1 dimethicone, polyglyceryl-2 caprate , Isostearyl Diglyceryl Succinate, Cetyl Phosphate, Sorbitan Sesquioleate,

Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone, Acrylates/C 10-30 Alkyl Acrylate Polyglyceryl-3 polydimethylsiloxyethyl dimethicone, acrylates / C 10-30 alkyl acrylates

Crosspolymer, Methyl Glucose Sesquistearate, Polyglyceryl-3 Methylglucose Distearate, Potassium Cetyl Phosphate, Polyglyceryl-2 Sesquiisostearate, Glyceryl Isostearate, Crosspolymer, Methyl Glucose Sesquistearate, Polyglyceryl-3 Methylglucose Distearate, Potassium Cetyl Phosphate, Polyglyceryl-2 Sesquiisostearate, Glyceryl Isostearate,

Behentrimonium Chloride, Cetearyl Glucoside, PEG/PPG-18/18 Dimethicone, Silikonemulga- toren im Allgemeinen enthalten. Beispiele: Behentrimonium chlorides, cetearyl glucosides, PEG / PPG-18/18 dimethicones, silicone emulsifiers in general. Examples:

Alle eingesetzten Stoffe weisen -sofern nichts anderes angegeben ist- einem 100%iger Aktivgehalt auf. Das Bakterium S. aureus (ATCC 12000) wurde aus einem nach EN 12353 angelegtenAll substances used have-unless otherwise stated-a 100% active content. The bacterium S. aureus (ATCC 12000) was from a according to EN 12353

Cryoröhrchen auf einer entsprechenden, platte (TSA-Agar, Fa. Heipha) ausgestrichen und bei 37°C 24 Stunden bebrütet. Von den gewachsenen Bakterien wurde eine zweite Passage angelegt, die im Suspensionstest eingesetzt wurde. Eine Impföse der Bakterien wurde zu 10mL LB-Medium (37g Hin-Herz-Bouillon (Fa. Merck) auf 11 Wasser) und 5g Glasperlen mit 4mm Durchmesser gegeben und 3 Minuten gevortext. Anschließend wurde diese Bakteriensuspension auf eine OD von 0,08 eingestellt. Die eingestellte Bakteriensuspension wurde dann 1 :20 mit LB-Medium verdünnt, um eine Keimzahl von ungefähr 2*105 zu gewährleisten. Diese Bakteriensuspension wurde anschließend für den Test eingesetzt. Der Suspensionstest wurde mittels TECAN-Pipettierroboter durchgeführt. Hierzu wurden 800μΙ_ der zu testenden Wirkstofflösungen, 10ΟμΙ H20 und 100 μΙ der Bakteriensuspension in Eppendorfgefäßen ohne Deckel mit aufgeschweißter Folie im Thermoschüttler vorgelegt. Nach 20, 60 und 180 Minuten bei 37°C und 1200rpm wurden aus den Eppendorfgefäßen im Thermoschüttler jeweils 100μΙ_ entnommen und zu 900μΙ_ LB-Medium pipettiert (10"1-Cryotubes on a corresponding plate (TSA agar, Heipha) struck and incubated at 37 ° C for 24 hours. From the grown bacteria, a second passage was created, which was used in the suspension test. A loop of the bacteria was added to 10mL LB medium (37g Hin-Herz broth (Merck) to 11 water) and 5g 4mm diameter glass beads and vortexed for 3 minutes. Subsequently, this bacterial suspension was adjusted to an OD of 0.08. The adjusted bacterial suspension was then diluted 1:20 with LB medium to ensure a bacterial count of approximately 2 * 10 5 . This bacterial suspension was then used for the test. The suspension test was carried out by means of a TECAN pipetting robot. To this end, 800μΙ_ of the drug solutions to be tested, 10ΟμΙ H20 and 100 μΙ of the bacterial suspension were placed in Eppendorf tubes without lid with welded foil in the thermal shaker. After 20, 60 and 180 minutes at 37 ° C. and 1200 rpm, 100 μl each were taken from the Eppendorf tubes in the thermal shaker and pipetted to 900 μl LB medium (10 μl ) .

Verdünnung). Diese Verdünnungen wurden mittels Spiralplatter auf Agarplatten ausplattiert. Eine Ausnahme stellt hier die Kontrolle da, die nochmal 1 :100 verdünnt wurde (10"3- Verdünnug). Bei den Kontrollen wurden beide Verdünnungen ausplattiert, einschließlich des Zeitpunkts T=0 Minuten. Zum Schluss wurden die Platten bei 37°C 24 Stunden bebrütet und anschließend mit Hilfe des Countermaten ausgewertet. Dilution). These dilutions were plated out on agar plates using spiral plates. The only exception is the control, which was diluted 1: 100 again (10 "3 dilution) and the controls were plated with both dilutions, including time T = 0 minutes, and finally the plates were allowed to cure at 37 ° C for 24 hours incubated and then evaluated using the Countermaten.

In der Auswertung wurde der Reduktionsfaktor bestimmt. Der Reduktionsfaktor ist der Faktor, um den die Zellzahl (CFU) der Testsubstanz im Vergleich zur Kontrolle reduziert wird. In the evaluation, the reduction factor was determined. The reduction factor is the factor by which the cell number (CFU) of the test substance is reduced compared to the control.

CFU (Kontrolle) CFU (control)

; - = Reduktionsfaktor  ; - = reduction factor

CFU {Testsubstanz) getestete Wirkstofflösungen:  CFU {test substance) tested drug solutions:

10 ppm Silver SDC 10 ppm Silver SDC

8 ppm Silver SDC  8 ppm Silver SDC

0,01 % Benzethoniumchlorid  0.01% benzethonium chloride

10 ppm Silver SDC + 0,01 % Benzethoniumchlorid  10 ppm Silver SDC + 0.01% benzethonium chloride

8 ppm Silver SDC + 0,01 % Benzethoniumchlorid Die Rohstoffe wurden mit Hilfe eines Lösungsvermittlers (2,5% Peg 40 = Hydrogenated Cas- tor Oil) gelöst. 8 ppm Silver SDC + 0.01% Benzethonium Chloride The raw materials were dissolved using a solubilizer (2.5% Peg 40 = Hydrogenated Cator Oil).

Folgende Reduktionsfaktoren konnten erreicht werden: The following reduction factors could be achieved:

Figure imgf000007_0001
Figure imgf000007_0001

10ppm Silber zeigen eine Reduktionsfaktor von 3, 0,01 % Benzethoniumchlorid zeigen einen Reduktionsfaktor von 4 und die Kombination 10ppm Silber und 0,01 % Benzethoniumchlorid zeigen nicht den Faktor 7 wie arithmetisch zu erwarten sondern überraschenderweise von 81.  10ppm silver show a reduction factor of 3, 0.01% benzethonium chloride show a reduction factor of 4 and the combination 10ppm silver and 0.01% benzethonium chloride do not show the factor 7 as arithmetically expected but surprisingly from 81.

Dieser Effekt lässt sich sogar mit 8 ppm (siehe Tabelle) wiederholen, so dass es sich nicht um einen zufällig beobachteten Effekt handeln kann. This effect can even be repeated at 8 ppm (see table), so it can not be a randomly observed effect.

Hydrodispersionsqel Hydrodispersionsqel

1 2 3 4 5  1 2 3 4 5

Cyclomethicone D5 8 10 5 3 —  Cyclomethicone D5 8 10 5 3 -

Dimethicone 200 est. — — — — 3  Dimethicone 200 est. - - - - 3

Dimethiconol (Dow Corning 1501 Fluid) 1 2 3 — 3  Dimethiconol (Dow Corning 1501 Fluid) 1 2 3 - 3

Ethanol 1 ,0 5,0 7,5 1 ,5 3,0 Ethanol 1, 0 5.0 7.5 1, 5 3.0

Natriumpolyacrylat (Cosmedia SP) 0,2 0,3 0,3 0,4 0, 10Sodium polyacrylate (Cosmedia SP) 0.2 0.3 0.3 0.4 0, 10

Methylpropandiol 2 3 4 5 — Methylpropanediol 2 3 4 5 -

Glycerin 9 15 5 7,5 25 Glycerol 9 15 5 7,5 25

Carbomer (Carbopol 981 ) 0,2 0,3 0,2 0,4 0, 15Carbomer (Carbopol 981) 0.2 0.3 0.2 0.4 0.15

Acrylat.es/C10-30Alkyl Acrylate Crosspoly- 0,2 0, 15 0,3 0,4 0, 10 mer (Pemulen TR 2) Acrylate.es/C10-30Alkyl Acrylate Crosspoly- 0.2 0, 15 0.3 0.4 0, 10 mer (Pemulen TR 2)

Carrageenan (Chondrus Crispus) (Gelcarin) — — — — 2  Carrageenan (Chondrus Crispus) (Gelcarin) - - - - 2

Hamamelis Extrakt Hamamelis (Extrakt PG) 0, 1 0,2 0,3 0,4 —  Hamamelis extract Hamamelis (extract PG) 0, 1 0.2 0.3 0.4 -

Parfüm q.s. q.s. q.s. q.s. q.s.  Perfume q.s. q.s. q.s. q.s. q.s.

Silbercitrat (Tinosan SDC) 0,4 0,3 0,5 0,4 0,6 Silver citrate (Tinosan SDC) 0.4 0.3 0.5 0.4 0.6

Benzethoniumchlorid 0,5 1 ,0 0,05 0,2 0, 1Benzethonium chloride 0.5 1, 0 0.05 0.2 0, 1

Wasser ad 100 ad 100 ad 100 ad 100 ad 100 O/W-Emulsion Water ad 100 ad 100 ad 100 ad 100 ad 100 O / W emulsion

6 7 8 9 106 7 8 9 10

Glycerylstearatcitrat 2,4 2,0 2,0 2,0 2,4Glyceryl stearate citrate 2.4 2.0 2.0 2.0 2.4

Medizinisches Weissöl (Shell Ondina Oil G 6,0 6,0 6,0 White medicinal oil (Shell Ondina Oil G 6.0 6.0 6.0

37) 37)

Myristylmyristat 3,0 — — — 3,0 Myristyl myristate 3.0 - - - 3.0

Isopropylpalmitat — 3,0 3,0 3,0 —Isopropyl palmitate - 3.0 3.0 3.0 -

Caprylic/Capric Triglycerid 4,0 — — — 4,0Caprylic / Capric Triglyceride 4.0 - - - 4.0

Lineares Silikonöl (BRB Silicone Oil DM 100 2,0 1 ,0 1 ,0 1 ,0 2,0 EP) Linear silicone oil (BRB Silicone Oil DM 100 2.0 1, 0 1, 0 1, 0 2.0 EP)

Propylparaben 0,2 0, 1 0,1 0, 1 0,2 Propylparaben 0.2 0, 1 0.1 0, 1 0.2

Sorbitanstearat 0,8 — — — 0,8Sorbitan stearate 0.8 - - - 0.8

Octyldodecanol 1 ,0 — — — 1 ,0Octyldodecanol 1, 0 - - - 1, 0

Cetearylalkohol 0,8 2,0 2,0 2,0 0,8Cetearyl alcohol 0.8 2.0 2.0 2.0 0.8

Phenoxyethanol 0,6 0,5 0,5 0,5 0,6Phenoxyethanol 0.6 0.5 0.5 0.5 0.6

Glycerin 6,5 — — — 6,5Glycerol 6.5 - - - 6.5

Natriumpolyacrylat (Cosmedia SP) 0, 19 0, 19 0, 19 0, 19 0,19Sodium polyacrylate (Cosmedia SP) 0, 19 0, 19 0, 19 0, 19 0.19

Xanthan Gum (Xanthan Gum E 415 food 0,2 0,2 grade) Xanthan Gum (Xanthan gum E 415 food 0.2 0.2 grade)

Methylparaben 0,3 0,3 0,3 0,3 0,3 Methyl paraben 0.3 0.3 0.3 0.3 0.3

Ethanol 3,0 — — — 3,0Ethanol 3.0 - - - 3.0

Parfüm 0,3 0,3 0,3 0,3 0,6Perfume 0.3 0.3 0.3 0.3 0.6

Lauroylethylarginat (Aminat G) 1 ,0 — 0,5 — —Lauroylethylarginate (aminate G) 1, 0 - 0.5 - -

Silbercitrat (Tinosan SDC) 0,4 0,3 0,5 0,4 0,6Silver citrate (Tinosan SDC) 0.4 0.3 0.5 0.4 0.6

Benzethoniumchlorid — 0, 1 — 0,07 0,05Benzethonium chloride - 0, 1 - 0.07 0.05

Wasser ad 100 ad 100 ad 100 ad 100 ad 100 Water ad 100 ad 100 ad 100 ad 100 ad 100

O/W Emulsionen O / W emulsions

1 2 3 4 5 61 2 3 4 5 6

Panthenol 1 ,50 — — 0,70 — 0,00Panthenol 1, 50 - - 0.70 - 0.00

Silbercitrat (Tinosan SDC) 0,4 0,3 0,3 0,5 0,4 0,4Silver citrate (Tinosan SDC) 0.4 0.3 0.3 0.5 0.4 0.4

Benzethoniumchlorid 1 0, 12 0, 12 0,5 0,07 0,07Benzethonium chloride 1 0, 12 0, 12 0.5 0.07 0.07

Paraffinum Liquidum (Shell On- dina 933 HRD) — 3,00 3,00 Paraffinum Liquidum (Shell Ondina 933 HRD) - 3.00 3.00

Isopropyl Palmitat 1 ,00 — — — — — Isopropyl palmitate 1, 00 - - - - -

Caprylic/Capric Triglycerid — 3,00 3,00 0,00 1.00 1 .00Caprylic / Capric Triglyceride - 3.00 3.00 0.00 1.00 1 .00

Cetearylalkohol — — — 2,50 4.00 4.00Cetearyl alcohol - - - 2.50 4.00 4.00

Cetylalkohol — 3,00 3,00 — — —Cetyl alcohol - 3.00 3.00 - - -

Paraffinum Liquidum (Shell Paraffin Liquidum (Shell

Ondina 927) 3,00 3,00 Ondina 927) 3.00 3.00

Dimethicon 200 est — 3,00 3,00 — 0.50 0.50 Dimethicone 200 est - 3.00 3.00 - 0.50 0.50

Cyclomethicon D5 — 3,00 3,00 — — —Cyclomethicone D5 - 3.00 3.00 - - -

C12-15 Alkylbenzoat — — — — 2.00 2.00C12-15 alkyl benzoate - - - - 2.00 2.00

Butyrospermum Parkii Butter Butyrospermum Parkii butter

(Shea Butter) 0,50 0,50 0,00 (Shea butter) 0,50 0,50 0,00

Dicaprylylether — — — 10,00 — — Dicaprylyl ether - - - 10.00 - -

Dicaprylylcarbonat 2,00 — — 0,00 — —Dicaprylyl carbonate 2.00 - - 0.00 - -

Glyceryl Stearate — 1 ,20 1 ,20 2,40 2,40 2,40Glyceryl stearates - 1, 20 1, 20 2.40 2.40 2.40

Tapiocastärke aq. (Tapioca Tapioca starch aq. (Tapioca

Pure) 1 ,00 Pure) 1, 00

Glycerin 5,00 8,00 10,00 8,00 10,00 8,00 Glycerine 5.00 8.00 10.00 8.00 10.00 8.00

Butylenelykol — — — 1 ,00 — —Butylene glycol - - - 1, 00 - -

Zitronensäure 0.0050 — — — — —Citric acid 0.0050 - - - - -

Natronlauge aq 45% 0,35 0,01 0,01 0,25 1 ,00 1 ,00Sodium hydroxide aq 45% 0.35 0.01 0.01 0.25 1, 00 1, 00

Polyglyceryl-10 Myristat — 1 ,80 — — 1 ,00 0,00Polyglyceryl-10 myristate - 1, 80 - - 1, 00 0.00

Polyglyceryl-10 Stearat 0,70 — 1 ,80 1 ,00 — 1 ,00Polyglyceryl-10 Stearate 0.70 - 1, 80 1, 00 - 1, 00

Carbopol 981 0,50 0,02 0,02 — — 0,00Carbopol 981 0.50 0.02 0.02 - - 0.00

Acrylic Acid/VP Crosspolymer Acrylic Acid / VP Crosspolymer

(Ultrathix P-100) — 0,50 0,75 0,75(Ultrathix P-100) - 0.50 0.75 0.75

Wasser ad 100 ad 100 ad 100 ad 100 ad 100 ad 100Water ad 100 ad 100 ad 100 ad 100 ad 100 ad 100

Trinatrium EDTA aq. 1 ,00 1 ,00 1 ,00 1 ,00 Ethylhexylmethoxycinnamat + Trisodium EDTA aq. 1, 00 1, 00 1, 00 1, 00 Ethylhexyl methoxycinnamate +

BHT 2,00 BHT 2.00

Butyl Methoxydibenzoylmethane — — — — 2,00 2,00 Butyl Methoxydibenzoylmethane - - - - 2.00 2.00

Phenylbenzimidazolesulfonsäure — — — — 2,00 2,00Phenylbenzimidazolesulfonic acid - - - - 2.00 2.00

Ethylhexylsalicylat — — — — 2,00 2,00Ethylhexyl salicylate - - - - 2.00 2.00

Titandioxid+ Trimethoxycaprylyl- silan (Tego Sun T 805) 0.3600 Titanium dioxide + trimethoxycaprylylsilane (Tego Sun T 805) 0.3600

Octocrylen — — — — 2,00 2,00 Octocrylene - - - - 2.00 2.00

Parfüm — 0.35 0.35 — 0.20 0.20 Perfume - 0.35 0.35 - 0.20 0.20

W/O-Emulsionen W / O emulsions,

1 2 3 4 5 1 2 3 4 5

Triglycerindiisostearat 1 ,0 0,5 0,25 2,0 3,0Triglycerol diisostearate 1, 0 0.5 0.25 2.0 3.0

Diglycerindipolyhydroxystearat 1 ,0 1 ,5 1 ,75 3,0 2,0Diglycerol dipolyhydroxystearate 1, 0 1, 5 1, 75 3.0 2.0

Paraffinöl (Shell Ondina 917) 12,5 10,0 8,0 5,0 1 1 ,5Paraffin oil (Shell Ondina 917) 12.5 10.0 8.0 5.0 1 1, 5

Vaseline (Pionier 6787) 8,0 6,0 5,0 12,0 2,5Vaseline (Pioneer 6787) 8.0 6.0 5.0 12.0 2.5

Hydrierte Kokosglyceride 2,0 1 ,0 2,5 5,0 0,25Hydrogenated coconut glycerides 2.0 1, 0 2.5 5.0 0.25

Decyloleat 0,5 0,75 1 ,0 2,0 0,25Decyl oleate 0.5 0.75 1, 0 2.0 0.25

Octyldodecanol 0,5 1 ,0 0,75 3,0 0,25Octyldodecanol 0.5 1, 0.75 3.0 0.25

Aluminiumstearat 0,4 0,3 0,6 1 ,0 0,05Aluminum stearate 0.4 0.3 0.6 1, 0.05

Dicaprylylcarbonat 0, 1 0,05 0, 15 0,5 1 ,0 hydriertes Rizinusöl 0,5 0,75 1 ,0 2,5 5,0Dicaprylyl carbonate 0, 1 0.05 0, 15 0.5 1, 0 hydrogenated castor oil 0.5 0.75 1, 0 2.5 5.0

Chitosan — — 0,25 — —Chitosan - - 0.25 - -

Polyacrylsäure, Na-Salz (Cosmedia SP) — — — 0,15 0,25Polyacrylic acid, Na salt (Cosmedia SP) - - - 0.15 0.25

Magnesiumchlorid 0,5 0,6 0,5 0,7 1 ,0Magnesium chloride 0.5 0.6 0.5 0.7 1, 0

Glycerin 3,0 5,0 10,0 15,0 1 ,5Glycerine 3.0 5.0 10.0 15.0 1, 5

Milchsäure 0,5 0,9 0,2 — —Lactic Acid 0.5 0.9 0.2 - -

Parfüm q,s, q,s, q,s, q,s, q,s,Perfume q, s, q, s, q, s, q, s, q, s,

Ethanol 2,0 — 5,0 — —Ethanol 2.0 - 5.0 - -

Capryl-/Caprinsäuretriglycerid 2,0 2,5 3,0 5,0 0,5Caprylic / Capric Acid Triglyceride 2.0 2.5 3.0 5.0 0.5

Lauroylethylarginat (Aminat G) 1 ,0 — 0,5 — —Lauroylethylarginate (aminate G) 1, 0 - 0.5 - -

Silbercitrat (Tinosan SDC) 0,4 0,3 0,5 0,4 0,6Silver citrate (Tinosan SDC) 0.4 0.3 0.5 0.4 0.6

Benzethoniumchlorid — 0, 12 — 0,07 0,05Benzethonium chloride - 0, 12 - 0.07 0.05

Kaliumsorbat 0,04 0, 15 0,05 0,03 0,4Potassium sorbate 0.04 0, 15 0.05 0.03 0.4

Wasser ad 100 ad 100 ad 100 ad 100 ad 100 Water ad 100 ad 100 ad 100 ad 100 ad 100

Claims

Patentansprüche claims Kosmetische Zubereitung enthaltend eine Kombination aus quaternärem Ammoniumsalz und Silbercitrat, dadurch gekennzeichnet, dass bezüglich der Konservierung eine Synergie zu beobachten ist und damit die zur Konservierung notwendige Einsatzkonzentration herabgesenkt wird. Cosmetic preparation containing a combination of quaternary ammonium salt and silver citrate, characterized in that with respect to the preservation of a synergy is observed and thus the necessary for preservation use concentration is lowered. Zubereitung nach einem der vorangehenden Patentansprüche, dadurch gekennzeichnet, dass die quaternäre Ammoniumverbindung Benzethoniumchlorid ist. Preparation according to one of the preceding claims, characterized in that the quaternary ammonium compound is benzethonium chloride. Zubereitung nach einem der vorangehenden Patentansprüche, dadurch gekennzeichnet, dass die Zubereitung in Form einer w/o Emulsion, o/w Emulsion, w/o/w Emulsion, High Internal Phase Emulsion, w/si Emulsion, si/w Emulsion, eines Hydrogels, einer Gelecreme, eines Gels oder als feste Formulierung wie zum Beispiel eines Seifenstücks oder Lippenstiftes vorliegt. Preparation according to one of the preceding claims, characterized in that the preparation is in the form of a w / o emulsion, o / w emulsion, w / o / w emulsion, high internal phase emulsion, w / si emulsion, si / w emulsion, a hydrogel , a jelly cream, a gel or as a solid formulation such as a bar of soap or lipstick. Zubereitung nach einem der vorangehenden Patentansprüche, dadurch gekennzeichnet, dass Benzethoniumchlorid in einer Konzentration von 0,001 bis 0, 1 % vorliegt. Preparation according to one of the preceding claims, characterized in that benzethonium chloride is present in a concentration of 0.001 to 0, 1%. Zubereitung nach einem der vorangehenden Patentansprüche, dadurch gekennzeichnet, dass Silbercitrat in einer Konzentration von 1 bis 20 ppm vorliegt. Preparation according to one of the preceding claims, characterized in that silver citrate is present in a concentration of 1 to 20 ppm. Verwendung von Benzethoniumchlorid und Silbercitrat zur Verbesserung der Konservierung von kosmetischen Zubereitungen. Use of benzethonium chloride and silver citrate for improving the preservation of cosmetic preparations. Verwendung nach Patentanspruch 5, dadurch gekennzeichnet, dass Use according to claim 5, characterized in that Benzethoniumchlorid in einer Konzentration von 0,001 bis 0,1 % vorliegt. Benzethonium chloride is present in a concentration of 0.001 to 0.1%. Verwendung von Zubereitungen nach einem der vorangehenden Patentansprüche zur Herstellung von Deo-Zubereitungen und After Shave Produkten. Use of preparations according to one of the preceding claims for the production of deodorant preparations and aftershave products.
PCT/EP2011/054430 2010-07-19 2011-03-23 Preparations comprising benzethonium chloride and silver citrate Ceased WO2012019789A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE112011102427T DE112011102427A5 (en) 2010-07-19 2011-03-23 Preparations with benzethonium chloride and silver citrate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201010027627 DE102010027627A1 (en) 2010-07-19 2010-07-19 Preparations with benzethonium chloride and silver
DE102010027627.8 2010-07-19

Publications (1)

Publication Number Publication Date
WO2012019789A1 true WO2012019789A1 (en) 2012-02-16

Family

ID=44122052

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/054430 Ceased WO2012019789A1 (en) 2010-07-19 2011-03-23 Preparations comprising benzethonium chloride and silver citrate

Country Status (2)

Country Link
DE (2) DE102010027627A1 (en)
WO (1) WO2012019789A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012167902A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Cosmetic or dermatological preparations with improved microbiological stability
WO2012167900A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Cosmetic and dermatological emulsion preparations with improved perfume release
WO2012167905A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Polyethylene glycol-free cosmetic or dermatological preparations
WO2012167906A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Cosmetic or dermatological preparations with improved rheological properties
DE102016000277A1 (en) * 2016-01-15 2017-07-20 Beiersdorf Ag Cosmetic preparations containing benzethonium chloride and diols

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025061409A1 (en) * 2023-09-21 2025-03-27 Unilever Ip Holdings B.V. A cosmetic composition

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041573A1 (en) 1999-12-13 2001-06-14 Ethicon, Inc. Therapeutic antimicrobial compositions
WO2005020915A2 (en) * 2003-08-28 2005-03-10 Pure Bioscience Silver dihydrogen citrate compositions comprising a second antimicrobial agent
WO2005102046A1 (en) 2004-04-20 2005-11-03 William H. Harvey Company Antimicrobial skin treatment composition and methods for producing and using an antimicrobial skin treatment composition
US20060115440A1 (en) * 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
US20060254988A1 (en) * 2005-05-10 2006-11-16 Confirm Monitoring Systems, Inc. Methods and compositions for the treatment of water
JP2007284412A (en) 2006-04-12 2007-11-01 I-Nage:Kk Disinfectant disinfection cream
JP2008110999A (en) 2008-02-04 2008-05-15 Mandom Corp Antibacterial composition and deodorant agent
EP1964543A1 (en) 2007-03-02 2008-09-03 Takasago International Corporation Preservative compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1635771A2 (en) * 2003-04-18 2006-03-22 MERCK PATENT GmbH Cosmetic formulations comprising antimicrobial pigments
US20060210500A1 (en) * 2003-04-18 2006-09-21 Merck Patent Gmbh Formulations

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041573A1 (en) 1999-12-13 2001-06-14 Ethicon, Inc. Therapeutic antimicrobial compositions
WO2005020915A2 (en) * 2003-08-28 2005-03-10 Pure Bioscience Silver dihydrogen citrate compositions comprising a second antimicrobial agent
WO2005102046A1 (en) 2004-04-20 2005-11-03 William H. Harvey Company Antimicrobial skin treatment composition and methods for producing and using an antimicrobial skin treatment composition
US20060115440A1 (en) * 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
US20060254988A1 (en) * 2005-05-10 2006-11-16 Confirm Monitoring Systems, Inc. Methods and compositions for the treatment of water
JP2007284412A (en) 2006-04-12 2007-11-01 I-Nage:Kk Disinfectant disinfection cream
EP1964543A1 (en) 2007-03-02 2008-09-03 Takasago International Corporation Preservative compositions
JP2008110999A (en) 2008-02-04 2008-05-15 Mandom Corp Antibacterial composition and deodorant agent

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012167902A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Cosmetic or dermatological preparations with improved microbiological stability
WO2012167900A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Cosmetic and dermatological emulsion preparations with improved perfume release
WO2012167905A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Polyethylene glycol-free cosmetic or dermatological preparations
WO2012167906A3 (en) * 2011-06-07 2014-01-30 Beiersdorf Ag Cosmetic or dermatological preparations with improved rheological properties
DE102016000277A1 (en) * 2016-01-15 2017-07-20 Beiersdorf Ag Cosmetic preparations containing benzethonium chloride and diols
WO2017121538A1 (en) * 2016-01-15 2017-07-20 Beiersdorf Ag Cosmetic preparations containing benzethonium chloride and diols
EP3402455B1 (en) 2016-01-15 2021-01-20 Beiersdorf AG Cosmetic compositions containing benzethonium-chloride and diols

Also Published As

Publication number Publication date
DE112011102427A5 (en) 2013-05-02
DE102010027627A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
EP2255781B1 (en) Cosmetic preparation containing glucosyl glycerides and powder
WO2012019789A1 (en) Preparations comprising benzethonium chloride and silver citrate
DE102007005093A1 (en) Cosmetic preparation for the prophylaxis or treatment of skin pigmentation, contains a combination of active ingredients comprising salicylic and-or glycolic acid plus titanium dioxide and-or zinc oxide pigments
WO2010031522A1 (en) Oil/water active ingredient emulsion containing uv filter
EP2630990A2 (en) Lightweight, waterproof cosmetic preparation
EP1935394A1 (en) Light lotion
EP1844753A2 (en) Utilisation of ester quats in compositions as sand repellent substances
EP2094234B1 (en) Cosmetic formulation containing glucosyl glycerides and urea
EP1965870A2 (en) Sunscreen agent comprising merocyanines and triazines
DE202006011472U1 (en) Cosmetic preparation, useful to treat or prevent cellulite, comprises (2-hydroxyethyl)urea; urea; and one or more compounds e.g. folic acid, alpha-glucosylrutin, carnitine and natural or synthetic isoflavonoide
WO2007068700A1 (en) Pigment-containing sunscreens comprising merocyanines
EP4054727B1 (en) Sunscreen composition with low stickiness
JP5851725B2 (en) Water-based or oil-in-water emulsified makeup cosmetics
DE102008018786A1 (en) Tinted preparation for day care
EP2099426A1 (en) Cosmetic formulation having glucosyl glycerides and scented substances
EP2181698A2 (en) Cosmetic formula with siloxane elastomers and particulate material
EP1958609B1 (en) Cosmetic preparation with water-soluble UV filter and vinylpyrrolidone/acrylic acid copolymer
DE202008010003U1 (en) Cosmetic preparation with naphthyltriazines
DE202006011833U1 (en) Cosmetic composition, useful for e.g. skin caring, comprises alpha benzoyl cinnamic acid nitrile compounds e.g. 2-benzoyl-3-(4-methoxy-phenyl)-acrylonitrile and 3-(4-methoxy-phenyl)-2-(4-methyl-benzoyl)-acrylonitrile and polar oils
WO2008058720A1 (en) Cosmetic preparations containing guerbet alcohols
DE102006034529A1 (en) Cosmetic preparation, useful e.g. as repellents to protect against mosquitoes, as protective skin cream and to protect against UV-induced skin aging, comprises (2-hydroxyethyl)urea and hyaluronic acid
DE102006055045A1 (en) Use of one or more glucosyl glyceride e.g. to prepare a cosmetic preparation to treat or prophylaxis of cellulite, and as a protective skin cream, day or night cream, makeup products, and skin and/or hair caring agent
EP2451535A2 (en) Cosmetic preparation containing glycyrrhetinic acid
DE102007024346A1 (en) Cosmetic formulation for protecting skin aging, particularly UV-induced skin aging, and for use in cosmetic sprays as sun protective agents, comprises dihydropyridine ethyloxysulfate ester salt and hydoxybenzoyl benzoic acid hexyl ester
EP4608358A1 (en) Sunscreen composition comprising a human milk oligosaccharide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11709725

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 1120111024274

Country of ref document: DE

Ref document number: 112011102427

Country of ref document: DE

REG Reference to national code

Ref country code: DE

Ref legal event code: R225

Ref document number: 112011102427

Country of ref document: DE

Effective date: 20130502

122 Ep: pct application non-entry in european phase

Ref document number: 11709725

Country of ref document: EP

Kind code of ref document: A1